GAL and neoplasm: The in vivo dynamic study of GAL-MPA in tumor-bearing mice (HepG2, MCF-7, A549, HCT116, U87, MDA-MB-231, and S180) showed its high tumor-targeted ability with the maximal tumor/normal tissue ratio up to 6.8.